Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) [Phase 1]

View source ↗

Summary

Phase 1 trial updating the addition of lenalidomide to the EPOCH chemotherapy regimen for adult T-cell leukemia/lymphoma; the study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1 Infection
• T-cell Leukemia Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma | Phase 1 | Status: SUSPENDED